In this prospective population-based sample, childhood adversities were associated with a significantly increased risk of objectively verified cardiovascular disease, especially among women but to a lesser extent among men. More studies with prospective settings are needed to confirm the association and possible mechanisms.
ObjectiveTo examine difference in mortality between postal survey non-respondents and respondents.DesignA prospective cohort study with baseline survey in 1998 and comprehensive linkage to national mortality registers until 2005, the Health and Social Support study.SettingA population-based postal survey of the working-aged population in Finland in 1998.ParticipantsThe original random sample comprised 64 797 working-aged individuals in Finland (20–24, 30–34, 40–44, 50–54 years of age; 32 059 women and 32 716 men), yielding 25 898 (40.0%) responses in the baseline postal survey in 1998.Primary outcome measureRegistry-based primary causes of death encoded with the International Classification of Diseases (ICD-10).ResultsIn women, HR for total mortality was 1.75 (95% CI 1.40 to 2.19) times higher among the non-respondents compared with the respondents. In men, non-response was associated with a 1.41-fold (1.21–1.65) excess risk of total mortality. Non-response associated in certain age groups with deaths due to diseases in women and with deaths due to external causes in men. The most prominent excess mortality was seen for total mortality for both genders and for mortality due to external causes among men.ConclusionsPostal surveys result in slight underestimation of illness prevalence.
There were few differences between the ICP patients and control women except for a higher frequency of later hepatobiliary disease, breast cancer and hypothyreosis. Women with a history of ICP should be screened for hypothyreosis more readily than those without. The higher frequency of breast cancer warrants further research.
This research characterized FA10 clients at a Finnish OHS. Illnesses of the musculoskeletal system and mental and behavioral disorders were accentuated among FA10s. The stability of the FA10 group, along with their sickness absences and work disabilities, should be investigated further.
BackgroundApplying for medical school is the first and also one of the most important career choices a physician makes. It is important to understand the reasons behind this decision if we are to choose the best applicants for medical schools and enable them to pursue satisfying careers.MethodsRespondents to the Finnish Junior Physician 88, Physician 1998 and Physician 2008 studies were asked: “To what extent did the following factors influence your decision to apply for medical school?” In 1998 and 2008 the respondents were also asked: “If you were starting your studies now, would you start studying medicine?” and had to answer “Yes” or “No”. The odds ratios for the answer “No” were tested using logistic regression models.Results"Interest in people” was the main motive for starting to study medicine. “Good salary” and “Prestigious profession” were more important motives for males and “Vocation” and “Interest in people” for females. There were some significant changes in the motives for entering medicine in the 20-year period between studies. “Vocation” and “Wide range of professional opportunities” as important motives for entering medicine predicted satisfaction with the medical profession. DiscussionStrong inner motivation may indicate the ability to adapt to the demands of work as a physician.ConclusionsMedical schools should try to select those applicants with the greatest vocational inclination towards a medical career.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.